LETSGETCHECKED INC. (PRIVAPATH DIAGNOSTICS INC.)

Company Snapshot

Founded: 2015
Entity Type: Private
Region: Ireland
Headquarter: Dublin, Ireland
Key Geographics: Ireland, U.S.
Corporate Address: Unit 6, Adelphi House, George's Street Upper Dun Laoghaire, Co. Dublin, A96 YX9N, Ireland www.letsgetchecked.com

Company Overview

LetsGetChecked (formerly PrivaPath Diagnostics) is a prominent DTC genetic and health testing industry player. The company offers a range of at-home health tests that cover genetic, sexual health, and general wellness areas. PrivaPath Diagnostics Ltd is the registered company name of LetGetChecked but operates under the brand name LetsGetChecked to simplify its identity and make it more accessible to consumers.

In 2022, LetsGetChecked acquired Veritas Intercontinental, a company offering a complete genomic testing portfolio, including the myGenome service, exome-based genetic testing, and genetic services for maternal-fetal medicine. In 2020, Veritas Intercontinental transferred all its operations to Europe.

This acquisition significantly broadens LetsGetChecked’s testing capabilities, enabling it to provide advanced genomic services such as WGS and specialized panels for pharmacogenomics (PGx), cancer screening, carrier screening, and maternal-fetal testing. Veritas Genetics' cutting-edge genomic technology enhances LetsGetChecked’s ability to deliver detailed and comprehensive genetic insights.

LETSGETCHECKED INC. (PRIVAPATH DIAGNOSTICS INC.) In Reports

Rare Disease Diagnostics: Technologies and Global Markets

BCC Research Report: Dive into Rare Disease Diagnostics Market report includes applications, industries, and services is given for 2023 and 2024, and then forecast through 2029.

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

BCC Research Market Analyst says global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a CAGR of 10.0%.

Direct to Consumer Testing Industry: Global Markets

BCC Market Research Report says Direct-to-Consumer (DTC) testing should grow from $1.4 billion in 2020 to $2.6 billion by 2025 with a compound annual growth rate of 14.2%.

Company's Business Segments

  • Product : Health Test Kits, TeleHealth, Pharmacy
  • Service : Medical Support, Consultations, Others

Applications/End User Industries

  • Healthcare
  • Hospitals
  • Clinics
  • Digital Health Providers
  • Consumers
AI Sentiment